Page last updated: 2024-10-28

halothane and Malignant Carcinoid Syndrome

halothane has been researched along with Malignant Carcinoid Syndrome in 3 studies

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, R1
Boulukos, PA1
Warner, RR1
Mason, RA1
Steane, PA1
Carlsson, C1

Other Studies

3 other studies available for halothane and Malignant Carcinoid Syndrome

ArticleYear
Failure of halothane and ketamine to alleviate carcinoid syndrome-induced bronchospasm during anesthesia.
    Anesthesia and analgesia, 1980, Volume: 59, Issue:8

    Topics: Adult; Anesthesia; Bronchial Spasm; Female; Halothane; Humans; Ketamine; Malignant Carcinoid Syndrom

1980
Carcinoid syndrome: its relevance to the anaesthetist.
    Anaesthesia, 1976, Volume: 31, Issue:2

    Topics: Anesthesia, General; Anesthetics; Blood Circulation; Bradykinin; Brain Stem; Halothane; Humans; Hypo

1976
[The anesthesiological significance of the carcinoid syndrome].
    Lakartidningen, 1972, Aug-02, Volume: 69, Issue:32

    Topics: Adult; Anesthesia; Anesthesia, General; Appendectomy; Appendiceal Neoplasms; Bradykinin; Carcinoid T

1972